From data intake to your signature.

1

Inputs

You select the testing pathway and supply the clinical context: diagnosis, stage, prior lines, comorbidities and treatment intent, plus relevant imaging. Twin works only with what it receives, and records what is missing.

2

Analysis and outputs

3

Review and signature

1. 1

   Treating team

   Pathway and data

   The treating oncologist selects the testing pathway; clinical, molecular and imaging data are integrated.

2. 2

   OnKommon Twin

   21-layer analysis

   AI-assisted analysis across the applicable layers produces structured findings for clinician review.

3. 3

   OnKommon Twin

   Structured report

   Executive summary, molecular findings, treatment options to evaluate, trial matches and longitudinal view.

4. 4

   Treating oncologist

   Review and signature

   Every report is reviewed and signed by the treating oncologist.

5. 5

   KPCIRC

   Molecular Tumour Board

   The signed report is then taken to KPCIRC's internal Molecular Tumour Board (MTB).

6. 6

   Treating oncologist

   Decision and continuity

   Clinical authority stays with the oncologist. New evidence can prompt reassessment during the six-month journey.

4

Secure handoff

5

Over six months

1. 01 · Baseline — Day 0

   Integrate the data. Build the Twin.

2. 02 · During months 0–6

   Review new findings inside the workflow.

3. 03 · End of month 6

   Review the evidence. Set the next pathway.

4. 04 · After six months

   Twin tracks

   Track 12Track 47Track 118